RCV_Landkarte

Operating in over 30 countries

The Regional Center Vienna (RCV), part of the German pharmaceutical company Boehringer Ingelheim, is responsible for over 30 countries in Central and Eastern Europe and in Asia. It is thus one of the company’s most important sites and is also a flagship enterprise in the Austrian capital. It employs around 1,500 people in medical research, production and administration.

As the center of Boehringer Ingelheim’s oncology research, Boehringer Ingelheim RCV GmbH & Co KG in Vienna is one of the most important sites within the global group of companies. We carry out research on new substances for cancer and other diseases and test them in clinical trials. The second focus is the development and production of biopharmaceuticals for ourselves and others.

As a regional center, we are responsible not only for the Austrian market but also for 33 countries in Central and Eastern Europe as far as Russia and Mongolia, and also Israel.

Our common goal is to achieve breakthroughs in the treatment of diseases and to advance medical research.

Vienna is special

The company’s expansion began in Vienna. The establishment of a subsidiary in 1948 was the first step towards the globalization of Boehringer Ingelheim. It was not only the first foreign subsidiary, however, but also the first site in the world where biopharmaceutical research was carried out. It was the birthplace in addition of biopharmaceutical production. We continue to invest heavily in Vienna. This benefits the company as a whole and also brings added value and attractive jobs to Vienna.

Boehringer Ingelheim - worldwide operations

Boehringer Ingelheim is one of the 20 leading pharmaceutical companies in the world. Its headquarters are in Ingelheim, Germany, and it has 145 affiliated companies worldwide. We provide secure jobs for over 50,000 people. In the last ten years alone we have added 10,000 employees to our workforce.

Boehringer Ingelheim is a family-owned company founded in 1885. Its main focuses are pharmaceutical research and the development, production, and marketing of new drugs with high therapeutic utility for human and veterinary medicine.